Orthofix Medical Inc.(OFIX)Earnings, Financials & Key Ratios

Key Thesis Takeaways

• Orthofix faces significant structural challenges as revenue growth decelerated to 1.6% in 2026Q1, signaling that post-merger synergies remain elusive.
• While the company maintains a robust 70.9% gross margin, persistent negative operating margins of -7.0% and rising debt levels suggest a difficult path to GAAP profitability.
• Investors should monitor the company's ability to manage its $234.4 million debt load and reduce reliance on stock-based compensation, which reached $20.8 million in 2025Q4, to stabilize its eroding equity base.